THE ROLE OF THE N-ACETYL CYSTEINE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES


Igit T., Al Halboosi J. K. İ., Kuşçu O., Bayir M. H.

VI. INTERNATIONAL HEALTH, ENGINEERING AND SCIENCES CONGRESS , Van, Türkiye, 16 - 18 Haziran 2023, ss.35-36

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Van
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.35-36
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

This paper highlights the potential of N-Acetyl cysteine (NAC) in the treatment of neurological diseases. NAC is the synthetic derivative of the endogenous amino acid L-site and is widely used in treatments, thanks to its mucolytic property as a precursor of glutathione (GSH'). NAC has attracted attention as a potential therapeutic agent in the treatment of neurological diseases in recent years. NAC is of great importance because it provides neuroprotective effects by reducing and neutralizing free radical damage in the brain. Oxidative stress is an important factor in the pathogenesis of neurological diseases and causes cell damage, inflammation, and neuronal degeneration. NAC acts as a precursor to a powerful antioxidant like GSH, helping to reduce oxidative stress in the brain. NAC also plays an important role in regulating neurotransmitters in the brain. It is particularly effective on glutamate and dopamine. Glutamate is an important neurotransmitter for nerve transmission. Hypersecretion of glutamate can lead to neurotoxicity and cell damage. NAC has a protective effect against the excessive release of glutamate. Although NAC is widely used in the treatment of lung diseases, its role in neurodegenerative diseases is not yet fully known. The antioxidant and anti-inflammatory effects of NAC may shed light on important factors in the pathogenesis of neurological diseases. Neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease occur as a result of neuronal losses, inflammation, and oxidative stress. In addition, NAC has a potential role in the treatment of psychiatric disorders. For example, diseases such as schizophrenia and bipolar disorder are associated with dopamine and glutamate dysregulation. By regulating the dopaminergic and glutamate systems, NAC may alleviate the symptoms of these diseases and contribute to the treatment. The anti-inflammatory effects of NAC are also effective in reducing inflammation, which plays an important role in the pathogenesis of many neurological diseases. For example, conditions such as multiple sclerosis, ALS, and neurological diseases due to infections are associated with inflammation. NAC can affect the course of these diseases by suppressing inflammation. Considering the reparative role and anti-inflammatory role of NAC in the blood and brain barrier, we think that it will be evaluated in detail in experimental studies with combined therapies, which can make important contributions to the literature. However, it needs to be supported by more clinical and experimental studies. Keywords: Glutathione, Oxidative Stress, N Acetyl Cysteine, Neurodegenerative Diseases